> Pharma giant Bristol-Meyers Squibb said it will pay a $300 million fine to settle a long-standing legal dispute with the government over its accounting practices. Story
> BusinessWeek looks at websites which let consumers comparison shop for the best hospitals and healthcare providers. Story
> A Florida hospital tackles its staffing problem with a plan that pays some specialists to be on-call. Story
> The New York Times examines the market for sleeping pills, which is expected to grow significantly with the arrival of the newest blockbuster, Sepracor's Lunesta. Story
> The Washington Post reports on research which suggests that it may be possible to harvest useful stem cell lines without harming human embryos, a theory many scientists dispute. Story
> Researchers developing the newest generation of HIV-tests face trade-offs between speed and accuracy. Story
> Once disparaged at most major medical schools, alternative medicine appears to be winning acceptance. Story
> Medicare's chief medical officer, Sean R. Tunis, must pay a fine of $20,000 in a case involving charges that he falsified documents showing he had met continuing medical education requirements. Story
> In California, the Institute for Regenerative Medicine faces controversy as lawmakers campaign for stricter oversight of the state's stem cell research initative. Story
> "Mini-medical insurance" plans are increasingly popular with employers. Critics are up in arms about them, however. Story
> The FDA is investigating the outbreak of cyclosporiasis, which made several hundred people ill in Florida between March and April. Story
And Finally... The Los Angeles Times looks at med bloggers. Story